InvestorsHub Logo
Followers 0
Posts 38
Boards Moderated 0
Alias Born 01/24/2011

Re: None

Saturday, 02/10/2018 9:05:58 PM

Saturday, February 10, 2018 9:05:58 PM

Post# of 6444
They updated website to 2018. The co. Only has value in the patents and the scientists. They are in the middle of ph 2 on cancer trials. Haig ran the co. In the ground before the RS. 2 large investment groups bought in then sold out in mid 2017. As long as Karen is in the deal then they have a chance. Not sure who is backing Haig though. It is a mystery to me? No one seems to be dumping shares?

This is a long term deal, all or nothing. Ph 3 would start ne t year if 2 is successful. This is cutting edge tech, still 50_50 to me.